73
              
            
            
              
                Sergio Aguilar-Huergo
              
            
            
              
                Seguimiento ambulatorio del lupus
              
            
            
              su predisposición a colaborar en este y otros estudios y el cariño
            
            
              que nos transmiten.
            
            
              
                REFERENCIAS
              
            
            
              1. Jimenez-Alonso J, Hidalgo-Tenorio C, Sabio-Sánchez JM, Jáimez-
            
            
              Gámiz L. Lupus Eritematoso sistémico. En Manual de enfermedades sis-
            
            
              témicas. Ed. Ergon. 2007; 3-49.
            
            
              2. Barber C, Gold WL, Fortin PR. Infections in the lupus patient:
            
            
              perspectives on prevention. Curr Opin Rheumatol. 2011; 23:358-65.
            
            
              3. Schoenfeld SR, Kasturi S, Costenbader KH. The epidemiology of
            
            
              atherosclerotic cardiovascular disease among patients with SLE: A syste-
            
            
              matic review. Semin Arthritis Rheum. 2013 Feb 16. S0049-0172(12)00284-
            
            
              3. 10.1016/j.semarthrit.2012.12.002
            
            
              4. Urowitz MB, Gladman DD, Tom BD, Ibañez D, Farewell VT. Chang-
            
            
              ing patterns in mortality and disease outcomes for patients with systemic
            
            
              lupus erythematosus. J Rheumatol. 2008;35:2152-8.
            
            
              5. Hochberg, MC. Updating the American College of Rheumatology
            
            
              Revised Criteria for the Classification of Systemic Lupus Erythematosus.
            
            
              Arthritis Rheum 1997; 40:1725.
            
            
              6. Manzi S, Selzer F, Sutton-Tyrrel K, et al. Prevalence and risk fac-
            
            
              tors of carotid plaque in women with systemic lupus erythematosus. Ar-
            
            
              thritis Rheum 1999; 42:51-60.
            
            
              7. Bruce IN. Not only but also: factors that contribute to accelerated
            
            
              atherosclerosis and premature coronary heart disease in systemic lupus
            
            
              erythematosus. Rheumatology 2005;44:1492-502.
            
            
              8. Sabio JM, Vargas-Hitos J, Zamora-Pasadas M, et al. Metabolic syn-
            
            
              drome is associated with increased arterial stiffness and biomarkers of
            
            
              subclinical aterosclerosis in patients with systemic lupus erythematosus. J
            
            
              Rheumatol. 2009;36:2204-11.
            
            
              9. Peralta-Ramirez MI, Jiménez-Alonso J, Godoy-García JF, Pérez-
            
            
              García M. The effects of daily stress and stressful life events on the clinical
            
            
              symptomatology of patients with lupus erythematosus Psychosom Med.
            
            
              2004;66:788-94.
            
            
              10. Navarrete-Navarrete N, Peralta-Ramírez MI, Sabio-Sánchez JM,
            
            
              et al. Efficacy of cognitive behavioural therapy for the treatment of chron-
            
            
              ic stress in patients with lupus erythematosus: a randomized controlled
            
            
              trial. Psychother Psychosom. 2010;79:107-15.